Health Canada has issued a market authorization with conditions for Voxzogo (vosoritide for injection) for the treatment of achondroplasia – Biomarin International
Health Canada has issued a Notice of Compliance with conditions (NOC/c) for Voxzogo (vosoritide for injection) a modified recombinant human C-type natriuretic peptide 39 (CNP-39) for the treatment… read more.
